DGAP-News: Executive Board and Supervisory Boards of Deutsche EuroShop AG recommend shareholders tender their shares into offer by Oaktree and CURA
2022. június 21., kedd, 14:39
Executive Board and Supervisory Boards of Deutsche EuroShop AG recommend shareholders tender their shares into offer by Oaktree and CURA
Within the scope of their fairness opinions prepared for the Company, Deutsche Bank and Rothschild & Co also conclude that the offer consideration is fair, from a financial point of view, to the shareholders of Deutsche EuroShop AG. The detailed joint reasoned statement of the Executive Board and the Supervisory Board of the Company pursuant to Section 27 para. 1 of the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz – WpÜG) is published on the Company’s website at https://www.deutsche-euroshop.com/Takeover-Offer. Shareholders of Deutsche EuroShop AG can still accept the offer, presumably until 7 July 2022. The Offer is subject to a minimum acceptance threshold of 50.0% plus one Share (including certain shares already held by Mr. Alexander Otto and entities controlled by him, including Kommanditgesellschaft CURA Vermögensverwaltung G.m.b.H. & Co.) and certain other customary conditions, including merger control clearance of the acquisition by the European Commission or the competent authorities in individual member states of the European Union, as applicable. The transaction is expected to close in the third quarter of 2022. Deutsche EuroShop - The Shopping Center Company
|
Language: | English |
Company: | Deutsche EuroShop AG |
Heegbarg 36 | |
22391 Hamburg | |
Germany | |
Phone: | +49 (0)40 413 579-0 |
Fax: | +49 (0)40 413 579-29 |
E-mail: | [email protected] |
Internet: | www.deutsche-euroshop.de |
ISIN: | DE0007480204 |
WKN: | 748020 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1380433 |
End of News | DGAP News Service |
1380433 21.06.2022
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]